COMPLETE TEST BANK (CHAPTERS 1-20) APPLIED
PATHOPHYSIOLOGY A CONCEPTUAL APPROACH 4TH EDITION
239 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
APPLIED PATHOPHYSIOLOGY (4TH EDITION) - JUDI NATH - COMPLETE TEST BANK (CHAPTERS 1-20)
APPLIED PATHOPHYSIOLOGY A CONCEPTUAL APPROACH 4TH EDITION. It contains 239 carefully selected
questions that reflect the most current exam content and testing strategies. Each question is accompanied by a
correct answer and a detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical
reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 239 Questions
Foundations - Application - Applied Pathophysiology 4th Edition JUDI NATH Complete BANK Chapters 1
20 Applied Pathophysiology A Conceptual Approach 4th Edition Applied Pathophysiology Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Applied Pathophysiology 4th 1-40 Chronic, Mechanism, Explains, Disease, Likely
Edition JUDI NATH Complete
BANK Chapters 1 20 Applied
Pathophysiology A
Conceptual Approach 4th
Edition Applied
Pathophysiology Graduate
Chronic 41-80 Explains, Mechanism, Development, Primary, Acute
Mechanism 81-120 Explains, Chronic, Likely, Develops, Disease
Disease 121-160 Chronic, Explains, Mechanism, Likely, Develops
Likely 161-200 Explains, Chronic, Pulmonary, Directly, Kidney
Develops 201-239 Explains, Chronic, Disease, Kidney, Likely
TOTAL 239 All questions include answers and detailed rationales
,Section A - Applied Pathophysiology 4th Edition JUDI
NATH Complete BANK Chapters 1 20 Applied
Pathophysiology A Conceptual Approach 4th Edition
Applied Pathophysiology Graduate
Q1.
In a cell, a mutation in the gene encoding the regulatory subunit of protein kinase A (PKA)
renders it unable to bind cAMP. Which downstream effect is most likely to be impaired?
A. Phosphorylation of glycogen B. Activation of adenylyl cyclase
phosphorylase kinase
C. Hydrolysis of GTP by Gs alpha subunit D. Binding of epinephrine to beta-adrenergic
receptor
Correct: A - Phosphorylation of glycogen phosphorylase kinase
Rationale:PKA is activated by cAMP; if the regulatory subunit cannot bind cAMP, PKA
remains inactive, so it cannot phosphorylate downstream targets like glycogen phosphorylase
kinase. Adenylyl cyclase activation and GTP hydrolysis occur upstream of PKA, and receptor
binding is independent of PKA.
Q2.
A research study examines a tissue with chronic inflammation. Which cellular adaptation
is most likely to be observed in response to persistent cell injury?
A. Hypertrophy B. Dysplasia
C. Metaplasia D. Atrophy
Correct: C - Metaplasia
Rationale:Metaplasia is a reversible change where one adult cell type is replaced by another,
often due to chronic irritation. Hypertrophy is an increase in cell size, atrophy is a decrease,
and dysplasia is disordered growth often preneoplastic.
Q3.
Which of the following best describes the mechanism of action of loop diuretics in
treating edema?
A. Inhibition of Na+-K+-2Cl- cotransporter in B. Antagonism of aldosterone in the
the thick ascending limb collecting duct
C. Inhibition of carbonic anhydrase in the D. Blockade of sodium channels in the distal
proximal tubule convoluted tubule
Page 3
, Section A - Applied Pathophysiology 4th Edition JUDI NATH Complete BANK Chapters 1 20 Applied Pathophysiology A Conceptual Approach
4th Edition Applied Pathophysiology Graduate
Correct: A - Inhibition of Na+-K+-2Cl- cotransporter in the thick ascending limb
Rationale:Loop diuretics inhibit the Na+-K+-2Cl- cotransporter in the thick ascending limb of
the loop of Henle, causing potent diuresis. Aldosterone antagonists act in the collecting duct,
carbonic anhydrase inhibitors in the proximal tubule, and thiazides in the distal convoluted
tubule.
Q4.
A patient with chronic liver disease presents with jaundice and prolonged prothrombin
time. Which laboratory finding is most consistent with the pathophysiological
mechanism?
A. Decreased serum albumin and increased B. Elevated conjugated bilirubin and normal
serum ammonia unconjugated bilirubin
C. Increased serum creatinine and D. Elevated serum lipase and amylase
decreased GFR
Correct: A - Decreased serum albumin and increased serum ammonia
Rationale:Chronic liver disease impairs synthetic function, leading to decreased albumin and
clotting factors (prolonged PT), and impaired urea cycle increases ammonia. Conjugated
hyperbilirubinemia is more typical of biliary obstruction, while renal and pancreatic markers
are not directly related to liver synthetic dysfunction.
Q5.
A patient with a history of chronic obstructive pulmonary disease (COPD) develops cor
pulmonale. Which of the following is the most direct cause?
A. Pulmonary vasoconstriction leading to B. Systemic hypertension causing left
increased right ventricular afterload ventricular hypertrophy
C. Increased pulmonary blood flow due to D. Myocardial ischemia due to coronary
left-to-right shunt artery disease
Correct: A - Pulmonary vasoconstriction leading to increased right ventricular afterload
Rationale:COPD causes hypoxemia and hypercapnia, leading to pulmonary vasoconstriction
and increased pulmonary vascular resistance, which increases right ventricular afterload and
causes right heart failure (cor pulmonale). Systemic hypertension affects the left ventricle,
and left-to-right shunts cause volume overload, not pressure overload.
Q6.
A patient with type 1 diabetes mellitus accidentally administers an excessive dose of
insulin. Which of the following counter-regulatory hormones would be most important in
restoring euglycemia?
Page 4